As the Mississippi Senate considers a bill that would ban the use of pharmaceuticals and sex reassignment surgery for minors who think they are experiencing gender dysphoria, the state’s leading health coverage company has taken a firm stance against the procedures.
The Mississippi Division of Medicaid said it agreed with a report from the Florida Agency for Health Care Administration (pdf) concluding that there is a lack of conclusive evidence to support medical intervention for gender dysphoria in children and adolescents.
“Mississippi Medicaid concurs with Florida Medicaid’s determination that available medical literature provides insufficient evidence that sex reassignment through medical intervention is a safe and effective treatment for gender dysphoria,” said Drew Snyder, executive director of Mississippi Medicaid, in a Feb. 15 statement (pdf)….